Supplement × Supplement·a caution·Insufficient evidence

Dihexa + Resveratrol

Caution Insufficient evidence

Resveratrol affects cell-signaling pathways and may confound attempts to interpret an unapproved c-Met-active compound.

From the database

What the row says.

Every entry follows the same shape: what is happening, the mechanism, and the recommendation.

Substances
Pair type
Caution
Evidence
Insufficient
Source citations
1
Scope
Supplement × Supplement
Last verified
June 4, 2026
CautionInsufficient evidence

What is happening. Resveratrol affects cell-signaling pathways and may confound attempts to interpret an unapproved c-Met-active compound.

Mechanism. Overlapping cell-signaling and cancer-biology uncertainty.

Recommendation. Avoid experimental longevity or nootropic stacks involving dihexa.

Stack Score

How it moves the number.

Effect on the composite score

If both Dihexa and Resveratrol are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).

The full algorithm, the clamping rules, and four worked stacks are at /methodology/stack-score.

Sources

Sources, by evidence tier.

Every claim on this page is cited. PMIDs link straight to PubMed.

Reference material

1
  • 1Cecchi F et al. HGF/Met signaling in cancer. Eur J Cancer. 2010.Needs sourceNo link

Check your full routine

One pair was the worked example.

Drop your supplements and prescriptions into NutriStack and it runs every pair at once: every interaction, synergy, timing rule, and contraindication, each linked to its primary source.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.